(Q40562209)

21 September 2017

title

Characterization of FAMPAC, a newly identified human pancreatic carcinoma cell line with a hereditary background (English)

1 reference

21 September 2017

0 references

1 reference

8

Markus W Büchler

1 reference

21 September 2017

Sven Eisold

1

1 reference

21 September 2017

Eduard Ryschich

2

1 reference

21 September 2017

Michael Linnebacher

3

1 reference

21 September 2017

Thomas Giese

4

1 reference

21 September 2017

Dirk Nauheimer

5

1 reference

21 September 2017

Anja Wild

6

1 reference

21 September 2017

Detlef K Bartsch

7

1 reference

21 September 2017

Jan Schmidt

9

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

100

1 reference

21 September 2017

issue

9

1 reference

21 September 2017

page(s)

1978-1986

1 reference

describes a project that uses

21 September 2017

FAMPAC

0 references

cites work

Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

Pancreatic cancer in father and son.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

Characterization of six cell lines established from human pancreatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

CDKN2A germline mutations in familial pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

P16 gene in uncultured tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

BRCA2 germline mutations in male breast cancer cases and breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

Chromosomes 17 and 22 involved in marker formation in neurofibrosarcoma in von Recklinghausen disease. A cytogenetic and in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

A rapid banding technique for human chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

Recent discoveries in cancer genetics of exocrine pancreatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

Screening for CDKN2A mutations in hereditary melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

Genetics and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

7 January 2021

Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

7 January 2021

Familial carcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

7 January 2021

Pancreatic carcinoma in brothers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

7 January 2021

Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

7 January 2021

Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

7 January 2021

Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

7 January 2021

Hereditary pancreatitis and familial pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

7 January 2021

Nonrandom chromosomal rearrangements in pancreatic carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

7 January 2021

Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

7 January 2021

BRCA2 germline mutations in familial pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20193

7 January 2021

Identifiers

DOI

10.1002/CNCR.20193

1 reference

21 September 2017

1 reference